Mounjaro Mode of Action: How Tirzepatide Works (October 2026)

01 · The short answer

What is the mode of action of Mounjaro?

Mounjaro works by activating the receptors for two natural gut hormones, GIP and GLP-1, at the same time. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

02 · Is this relevant to you?

Do you need to understand the mechanism to use Mounjaro?

No, but knowing it makes the treatment make sense. The medicine is not a stimulant or a fat burner. It changes appetite signals and how quickly food moves through you, and that is why it is used alongside a reduced-calorie diet and increased physical activity rather than instead of them.¹

If you are deciding whether treatment is appropriate, the practical next step is a consultation. Our Mounjaro pen page shows current dose prices, and the free online consultation is reviewed by a GPhC-registered prescriber. If you are still weighing up weight-management options more broadly, our weight loss clinic hub is a good starting point.

Related guides: Mounjaro mechanism of action and Mounjaro duration of action.

03 · GIP and GLP-1 explained

What are GIP and GLP-1?

GIP and GLP-1 are natural gut hormones, and tirzepatide is designed to activate their receptors. The medicine activates two natural gut-hormone receptors at once: GIP and GLP-1.¹ Receptors are the docking points on cells that hormones attach to. When a medicine activates a receptor, the cell responds much as it would to the natural hormone.

The general term for a medicine that activates a receptor in this way is an agonist. That is why you will see tirzepatide described as a dual agonist in clinical literature: it is an agonist at both the GIP receptor and the GLP-1 receptor. Our guide to the action of GLP-1 explains the single-hormone approach in more depth.

What makes Mounjaro different is that it does not rely on GLP-1 alone.

04 · Appetite and fullness

How does Mounjaro reduce appetite?

Mounjaro helps regulate appetite, so most people feel fuller sooner and less hungry between meals.¹

It is worth being clear about what this does and does not mean. The medicine does not remove the need to plan meals, and it does not replace physical activity. Think of the medicine as making that plan easier to follow, not as doing the work for you.

People often ask how quickly this is felt. Our page on the onset of action goes through what to expect early on.

Appetite is also shaped by sleep, stress, routine and habit. The medicine changes one part of the picture. Noticing those patterns is a useful part of long-term success.

05 · Stomach emptying and insulin

What do slower stomach emptying and insulin response mean?

Tirzepatide slows how quickly the stomach empties, and it improves the way the body responds to insulin.¹ These are two separate effects, and they matter for different reasons.

Slower stomach emptying is part of why you feel full for longer after eating. It is also relevant to safety: because stomach emptying slows, the medicine can reduce how well oral contraceptive pills are absorbed.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ That is why your prescriber will ask about contraception and discuss it with you, and why you should follow the guidance in the patient information leaflet.¹³

The improved insulin response is the reason tirzepatide is also licensed for type 2 diabetes.¹ If you take insulin or sulfonylureas, your doses may need adjusting because of the risk of low blood sugar. That is a point to raise with your prescriber, not something to manage on your own.

Digestive side effects can relate to the slower movement of food through the system. Tell your prescriber about any new or lasting symptom, and you can report suspected side effects through the MHRA Yellow Card scheme.¹⁹

06 · Mounjaro versus semaglutide

How is Mounjaro's action different from semaglutide?

Mounjaro activates GIP and GLP-1 receptors, which distinguishes it from single-action GLP-1 medicines such as semaglutide (Wegovy and Ozempic).¹ Semaglutide is not a lesser medicine: it is a licensed, effective treatment, and many people do well on it. The difference is in the number of hormone pathways targeted.

The two also differ in how they are dosed. Wegovy pens are 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly, with titration steps after at least four weeks, reaching the 2.4mg maintenance dose from week 17.¹⁸ Mounjaro comes in six strengths, from 2.5mg to 15mg.¹ Both are once-weekly injections, unlike liraglutide, which is a daily injection.

SURMOUNT-5 was the first large head-to-head trial of tirzepatide and semaglutide for weight loss.¹⁵ For a side-by-side look at the pharmacology, see our page on Mounjaro versus Wegovy mechanism of action. If you are comparing treatment options, you can also look at the Wegovy pen.

Which suits you is a prescriber decision, taking in your health history, other medicines and what you have tried before. The mechanism is one input among several, not the whole answer.

07 · Mechanism and weight loss results

What does the mode of action mean for weight loss?

The appetite and stomach-emptying effects are what support weight loss, and the SURMOUNT-1 trial shows what that looked like on average. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² Trial averages do not predict your own result.

At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

As a worked example only: for someone starting at 100 kg, 20.9% is about 21 kg. That is the straight arithmetic of the trial average at the 15mg dose, not a forecast for any individual and not a timeline.

08 · How long it stays in the body

How long does tirzepatide stay in your system?

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹ That long half-life is what makes a once-weekly injection possible.

It also answers a common question. If you stop taking Mounjaro, the effect does not switch off overnight: the medicine leaves your system over four to five weeks. If you are thinking about stopping, speak to your prescriber first, so any plan is made with your health history in mind.

The weekly pattern matters in practice. Missing a dose, changing day or adjusting your own dose are all things to discuss with a prescriber and the patient information leaflet rather than improvise.

09 · Safety and who it suits

What should the mechanism make you aware of?

The way the medicine works explains many of its practical cautions, and the patient information leaflet is the full reference.¹³ Slower stomach emptying relates to digestive effects and to the contraception point. Insulin response matters if you take diabetes medicines.

Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation. This is why Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber.¹

Mounjaro (tirzepatide) is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · NHS and private access

Can you get Mounjaro on the NHS or privately?

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you choose private treatment, EverydayMeds is a GPhC-registered UK online pharmacy (registration 9012878). The consultation is free, the prescriber review is by a GPhC-registered prescriber, and Mounjaro is supplied through official LillyDirect supply, sourced directly from Eli Lilly. Delivery is free, next-day and tracked, in temperature-controlled packaging. All six doses are in stock.